Clinical Trial Update: Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing immunogenicity of two-dose versus three-dose schedules of combined Hepatitis B vaccines in children aged 2 to 18 months; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Laval University | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED